Evidence map›Paper›PMID 38276207›Full record

ReviewMicroorganisms2024

Asghar Ali, Khalid I AlHussaini

Open access · goldAbstract readReview
In one paragraph

Review in Microorganisms, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 83 papers, 8 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
83citing papers in PubMed, 8 pooled it
64.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

83 citing papers in PubMed, 8 syntheses or guidelines pooled it, 113 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. The impact ofFrontiers in cellular and infection microbiology · 2025
    Pooled it
  7. Pooled it
  8. Insights intoFrontiers in microbiology · 2024
    Pooled it
  9. An in-depth review on antimicrobial efficacy of melittin in vivo.World journal of microbiology & biotechnology · 2026
    Review
  10. Article
  11. Adjunctive Synbiotic Therapy forLife (Basel, Switzerland) · 2026
    Review
  12. Review
  13. Article
  14. Article
  15. Association betweenBMJ open gastroenterology · 2026
    Observational
  16. Article
  17. Article
  18. Low-Abundance and FragmentaryBiomolecules · 2026
    Article
  19. Fecal miR-146a as a Non-Invasive Biomarker forLife (Basel, Switzerland) · 2026
    Article
  20. Article

23 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Asghar AliClinical Biochemistry Laboratory, Department of Biochemistry, School of Chemical and Life Sciences, Jamia Hamdard, New Delhi 110062, India.ORCID 0000-0002-1574-4796
Khalid I AlHussainiDepartment of Internal Medicine, College of Medicine, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh 4233-13317, Saudi Arabia.ORCID 0009-0000-8467-8000
Imam Mohammad ibn Saud Islamic University · SAJamia Hamdard · IN

Funding

Deanship of Scientific Research Imam Mohammad Ibn Saud Islamic University IMSIU-RP23026
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

antibiotic resistancediagnostic toolspathogenesistreatment strategiestriple therapyvirulence factors

Identifiers

PMID38276207
PMCPMC10818838
OpenAlexW4391103850

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.